WallStSmart
FULC

Fulcrum Therapeutics Inc

NASDAQ: FULC · HEALTHCARE · BIOTECHNOLOGY

$7.15
-3.90% today

Updated 2026-04-29

Market cap
$522.15M
P/E ratio
P/S ratio
2.66x
EPS (TTM)
$-1.18
Dividend yield
52W range
$4 – $16
Volume
1.2M

Fulcrum Therapeutics Inc (FULC) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+2.2%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+0.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-10.3%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-14.0%
2025-10-29
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-26$-0.31-1.5%$8.98$8.38-6.7%
2025-10-29$-0.31-6.9%$10.00$8.60-14.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.31$-0.31-1.5%
2025-09-30$-0.29$-0.31-6.9%
2025-06-30$-0.29$-0.28+3.4%
2025-03-31$-0.33$-0.28+13.8%
2024-12-31$-0.29$-0.31-7.5%
2024-09-30$-0.41$-0.46-13.0%
2024-06-30$-0.01$0.87+8800.0%$80.00M+8990.9%
2024-03-31$-0.44$-0.43+2.3%
2023-12-31$-0.43$-0.40+7.0%$871000.00
2023-09-30$-0.43$-0.39+9.3%$759000.00
2023-06-30$-0.44$-0.38+13.6%$880000.00
2023-03-31$-0.46$-0.41+10.9%

Frequently asked questions

Has Fulcrum Therapeutics Inc beaten earnings estimates?
Fulcrum Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +2.2% over the last 4 quarters.
How does FULC stock react to earnings?
FULC stock has moved an average of -10.3% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.